Why your pension could be dealt a body blow as Trump eyes tariffs for Britain's top drug firms
found
a story from The Daily Mail 💩 › The Daily Mail
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock market - and also rival GSK, another stalwart of the FTSE 100.